中文English
ISSN 1001-5256
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

不确定期慢性HBV感染者可能获益于抗病毒治疗

徐京杭 徐小元 于岩岩

徐京杭,徐小元,于岩岩. 不确定期慢性HBV感染者可能获益于抗病毒治疗[J]. 临床肝胆病杂志, 2021, 37(11): 2539-2540. DOI: 10.3969/j.issn.1001-5256.2021.11.007
引用本文: 徐京杭,徐小元,于岩岩. 不确定期慢性HBV感染者可能获益于抗病毒治疗[J]. 临床肝胆病杂志, 2021, 37(11): 2539-2540. DOI: 10.3969/j.issn.1001-5256.2021.11.007
XU JH, XU XY, YU YY. Patients with chronic hepatitis B virus infection in the indeterminate phase may benefit from antiviral therapy [J]. J Clin Hepatol, 2021, 37(11): 2539-2540. DOI: 10.3969/j.issn.1001-5256.2021.11.007
Citation: XU JH, XU XY, YU YY. Patients with chronic hepatitis B virus infection in the indeterminate phase may benefit from antiviral therapy [J]. J Clin Hepatol, 2021, 37(11): 2539-2540. DOI: 10.3969/j.issn.1001-5256.2021.11.007

不确定期慢性HBV感染者可能获益于抗病毒治疗

DOI: 10.3969/j.issn.1001-5256.2021.11.007
详细信息
    通讯作者:

    于岩岩,yyy@bjmu.edu.cn

  • 中图分类号: R512.62

Patients with chronic hepatitis B virus infection in the indeterminate phase may benefit from antiviral therapy

  • [1] Chinese Society of Infectious Diseases, Chinese Medical Association, Chinese Society of Hepatology, Chinese Medical Association. Guidelines for the prevention and treatment of chronic hepatitis B (version 2019)[J]. J Clin Hepatol, 2019, 35(12): 2648-2669. DOI: 10.3969/j.issn.1001-5256.2019.12.007.

    中华医学会感染病学分会, 中华医学会肝病学分会. 慢性乙型肝炎防治指南(2019年版)[J]. 临床肝胆病杂志, 2019, 35(12): 2648-2669. DOI: 10.3969/j.issn.1001-5256.2019.12.007.
    [2] TERRAULT NA, LOK ASF, MCMAHON BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance[J]. Hepatology, 2018, 67 (4): 1560-1599. DOI: 10.1002/hep.29800.
    [3] HUANG DQ, LI X, LE MH, et al. Natural history and hepatocellular carcinoma risk in untreated chronic hepatitis B patients with indeterminate phase[J]. Clin Gastroenterol Hepatol, 2021, DOI: 10.1016/j.cgh.2021.01.019.[Online ahead of print]
    [4] SPRADLING PR, XING J, RUPP LB, et al. Distribution of disease phase, treatment prescription and severe liver disease among 1598 patients with chronic hepatitis B in the Chronic Hepatitis Cohort Study, 2006-2013[J]. Aliment Pharmacol Ther, 2016, 44 (10): 1080-1089. DOI: 10.1111/apt.13802.
    [5] YAO K, LIU J, WANG J, et al. Distribution and clinical characteristics of patients with chronic hepatitis B virus infection in the grey zone[J]. J Viral Hepat, 2021, 28 (7): 1025-1033. DOI: 10.1111/jvh.13511.
    [6] HSU YN, PAN CQ, ABBASI A, et al. Clinical presentation and disease phases of chronic hepatitis B using conventional versus modified ALT criteria in Asian Americans[J]. Dig Dis Sci, 2014, 59 (4): 865-871. DOI: 10.1007/s10620-014-3054-1.
    [7] DUAN M, CHI X, XIAO H, et al. High-normal alanine aminotransferase is an indicator for liver histopathology in HBeAg-negative chronic hepatitis B[J]. Hepatol Int, 2021, 15 (2): 318-327. DOI: 10.1007/s12072-021-10153-2.
  • 加载中
计量
  • 文章访问数:  150
  • HTML全文浏览量:  34
  • PDF下载量:  95
  • 被引次数: 0
出版历程
  • 收稿日期:  2021-09-13
  • 修回日期:  2021-09-13
  • 网络出版日期:  2021-11-16
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回